MA28368A1 - Modulateurs oxydecahydronaphtalene de hm74 - Google Patents

Modulateurs oxydecahydronaphtalene de hm74

Info

Publication number
MA28368A1
MA28368A1 MA29288A MA29288A MA28368A1 MA 28368 A1 MA28368 A1 MA 28368A1 MA 29288 A MA29288 A MA 29288A MA 29288 A MA29288 A MA 29288A MA 28368 A1 MA28368 A1 MA 28368A1
Authority
MA
Morocco
Prior art keywords
oxydecahydronaphtalene
modulators
oxydecahydronaphtalene modulators
Prior art date
Application number
MA29288A
Other languages
English (en)
Inventor
Anne Minnich
Theresa Kuntzweiler
Haifeng Eishingdrelo
Michael Angelastro
Stephan Henke
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MA28368A1 publication Critical patent/MA28368A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrrole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MA29288A 2004-02-20 2006-08-24 Modulateurs oxydecahydronaphtalene de hm74 MA28368A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20

Publications (1)

Publication Number Publication Date
MA28368A1 true MA28368A1 (fr) 2006-12-01

Family

ID=34910747

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29288A MA28368A1 (fr) 2004-02-20 2006-08-24 Modulateurs oxydecahydronaphtalene de hm74

Country Status (21)

Country Link
US (2) US7264937B2 (fr)
EP (1) EP1718293A1 (fr)
JP (1) JP2007526917A (fr)
KR (1) KR101145693B1 (fr)
CN (1) CN1929833A (fr)
AR (1) AR047708A1 (fr)
AU (1) AU2005216878B2 (fr)
BR (1) BRPI0507916A (fr)
CA (1) CA2556757C (fr)
CR (1) CR8537A (fr)
EC (1) ECSP066776A (fr)
IL (1) IL177106A (fr)
MA (1) MA28368A1 (fr)
ME (2) ME00059B (fr)
NO (1) NO20064214L (fr)
RS (1) RS20060472A (fr)
RU (1) RU2006133539A (fr)
TN (1) TNSN06235A1 (fr)
TW (1) TWI354552B (fr)
WO (1) WO2005082352A1 (fr)
ZA (1) ZA200606687B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603585A2 (fr) * 2003-03-14 2005-12-14 Bristol-Myers Squibb Company Polynucleotide codant un nouveau variant de recepteur de hm74, hgprbmy74 couple a une proteine g humaine
SG163577A1 (en) 2004-12-03 2010-08-30 Schering Corp Substituted piperazines as cb1 antagonists
RU2008133381A (ru) * 2006-01-18 2010-02-27 Шеринг Корпорейшн (US) Модуляторы каннабиноидного рецептора
WO2008130616A2 (fr) * 2007-04-19 2008-10-30 Schering Corporation Diaryl morpholines comme modulateurs des récepteurs cb1
EP2170847A2 (fr) * 2007-06-28 2010-04-07 Intervet International BV Pipérazines à substitution servant d'antagonistes des récepteurs cb1
RU2010102478A (ru) * 2007-06-28 2011-08-10 Интэрвэт Интэрнэшнл Б.Ф. (NL) Замещенные пиперазины как антагонисты св1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1998056820A1 (fr) * 1997-06-12 1998-12-17 Smithkline Beecham Corporation Recepteur hm74a
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
IL177106A (en) 2012-03-29
AR047708A1 (es) 2006-02-08
EP1718293A1 (fr) 2006-11-08
ZA200606687B (en) 2008-02-27
AU2005216878B2 (en) 2010-06-17
US20080045586A1 (en) 2008-02-21
ME00059B (me) 2010-06-10
WO2005082352A1 (fr) 2005-09-09
TWI354552B (en) 2011-12-21
CA2556757C (fr) 2011-05-03
US20050187263A1 (en) 2005-08-25
AU2005216878A1 (en) 2005-09-09
CN1929833A (zh) 2007-03-14
KR20060127982A (ko) 2006-12-13
IL177106A0 (en) 2006-12-10
RU2006133539A (ru) 2008-03-27
MEP17008A (en) 2010-06-10
ECSP066776A (es) 2006-11-16
NO20064214L (no) 2006-09-18
KR101145693B1 (ko) 2012-05-25
CR8537A (es) 2007-03-05
CA2556757A1 (fr) 2005-09-09
JP2007526917A (ja) 2007-09-20
TW200539864A (en) 2005-12-16
RS20060472A (en) 2008-11-28
TNSN06235A1 (en) 2007-12-03
US7264937B2 (en) 2007-09-04
BRPI0507916A (pt) 2007-07-10

Similar Documents

Publication Publication Date Title
ATE540027T1 (de) Tetrahydroindazol-cannabinoidmodulatoren
DK1720866T3 (da) Fremgangsmåde
DE602005012267D1 (de) N von geräten
DK1809978T3 (da) Modul-skydebane
ATE414693T1 (de) Neuartige cis-imidazoline
NO20050756D0 (no) Mikroelektromekaniske anordninger
DK2447252T3 (da) Theramuteinmodulatorer
ATE456558T1 (de) Gabanerge modulatoren
ATE419193T1 (de) Verschlusskappe
DE502005005196D1 (de) Direktional verfestigte bauteile
MA28373A1 (fr) Modulateurs furosemide de hm74
DE502005005664D1 (de) Chronograph
NO20043305D0 (no) Preparation of lodixanol
MA28368A1 (fr) Modulateurs oxydecahydronaphtalene de hm74
FR2869904B1 (fr) Modulateurs des recepteurs lxr
FI20055133A0 (fi) Iskulaite
AT500549B8 (de) Klärbecken
DE602005000466D1 (de) Einwegverschlusskappe
FR2877833B1 (fr) Correcteur de lordoses
DE502004008171D1 (de) Viskosekupplung
DE502005002684D1 (de) Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
DE502005004692D1 (de) Massageaufsatz
ATA13282004A (de) Massagegerät
DE112004001228A5 (de) Verschlusskappe
DOP2004000824A (es) Nuevos derivados de 2-piridinacarboxamida